Executive Series 26 Jun 18: Wattle Health Australia (WHA) CEO, Lazarus Karasavvidis, page-100

Most of us work on probabilities, especially at this end of the market but the question is about how robust is the share price in regards the business risk regarding its current activities and events that are mid-flight.

So share your view, what impact on the share price will a failure of SAMR approval for its cows milk application have do you think? Keep in mind we aren't talking the organic or goat milk products, just standard cow milk products.